Science 37® and PhysIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use remote biosensors and machine learning to build more robust data sets. This will help increase the number of digital biomarkers and generate insights from continuous data streams to more quickly and objectively demonstrate the safety and efficacy of treatments.

mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022

‘Double Agent’ in Healthcare Industry Will Promote a Truly Patient-Centric Agenda Bracknell, UK - 3 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for remote patient visits improves data integrity and monitoring. He will be sharing how the latest medical technologies meet patient care to create remarkable patient experiences, and the important factors to consider when selecting Healthcare Professionals for mobile health patient visits.

Qlucore appoints new Head of R&D

Qlucore appoints new Head of R&D

Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care

Leading Digital Health Company Expands Provider and Payer Customer Base as Demand for Patient Access Solutions Accelerates Across the Healthcare Industry

DFE Pharma appoints Martti Hedman as new CEO

DFE Pharma appoints Martti Hedman as new CEO The combination of his experience, culture and drive makes him an ideal fit for DFE Pharma for the next stages of growth Goch, Germany (7th February 2022) – DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, today announced that Martti Hedman has been appointed as the new Chief Executive Officer. An experienced business leader, Hedman will succeed Bas van Driel and assume responsibilities on 14th February. Van Driel decided to step down in order to allow the company to further grow after setting the company up for success.

Rho Clinical Development Expert Available for One-on-one Discussions at the 14th Annual Outsourcing in Clinical Trials West Coast

Rho, a full-service contract research organization (CRO), is sharing its clinical development expertise with attendees of the 14th Annual Outsourcing in Clinical Trials (OCT) West Coast conference, taking place at the Hyatt Regency San Francisco Airport from February 15-16, 2022. Rho’s Associate Director of Business Development Brennan Munley is offering one-on-one meetings with those interested in learning more about how Rho can help ensure an efficient and a successful drug development process.

DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development

DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week.

Lyniate Earns Best in KLAS® Distinction for Integration Engine Category

BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics

BioSkryb Genomics, a leader of single-cell genome amplification, and ALS Automated Lab Solutions GmbH, developers of a multi-patented spatial single cell and colony picking technology platform, today announced a U.S. distribution agreement to power comprehensive single cell plus spatial genomic analysis.

ZeOmega Named #1 Best in KLAS Top Performer for Payer Care Management Solutions 2022

Curebase Joins the SCRS Global Impact Partner Program

Curebase Joins the SCRS Global Impact Partner Program

New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis

Hello, Today, Thermo Fisher announced a new addition to its leading Applied Biosystems portfolio: a genetic analyzer that customers say is “the most intuitive and flexible sequencer we have ever used.” The Applied Biosystems SeqStudio Flex Series Genetic Analyzer builds on leading CE-technology to support customers performing Sanger sequencing or fragment analysis. Please find the press release below and online here and let me know if you have any questions or would like a high-res product photo.

PubHive Adds Single Sign-On Integration With Okta

New integration facilitates secure single sign-on (SSO) and user provisioning for life science companies using PubHive’s AI-powered scientific workflow automation SaaS platform

Alfa Chemistry Demonstrates Ability for Surface Analysis to Facilitate Materials Testing for Alternative Energy Industry

New BHM® COVID-19 lateral flow test passes UK government assessment

Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces that its new lateral flow test has passed phase 3a testing by the UK government. The new test is more sustainable than traditional lateral flow kits, producing 75% less plastic waste.

Watson-Marlow launches industry first augmented reality app for Sine pump maintenance

Leading the way in creative customer solutions, Watson-Marlow Fluid Technology Group (WMFTG) has launched the first in a series of augmented reality (AR) apps. Developed to enhance the customer experience and post-sales support for its products, the first app has been built for its Certa Sine pump. This is a pump renowned for meeting the highest standards in hygiene and cleanability, improving process efficiency and minimising total cost of ownership.

IDT UNVEILS NEW SOLUTION TO ACCELERATE HOMOLOGY-DIRECTED REPAIR GENOME EDITING RESEARCH

Domainex opens a dedicated new facility at Unity Campus to expand research operations

Domainex Ltd., a leading integrated medicines research services partner, today announces it has opened a facility of over 7,000 sq ft at Unity Campus in Sawston – Cambridge’s newest science and technology park encompassing Iconix Park and The Works, and owned by leading regional property and investment firm Howard Group.

DISYS Launches PVAutomate, an Innovative Healthcare Solution Automating Critical Functions in Pharmacovigilance Operations

Digital Intelligence Systems, LLC (DISYS), a global technology services firm, launches its innovative healthcare automation solution, PVAutomate, which automates critical compliance workflows and data management in pharmacovigilance operations.

AES Clean Technology Accelerates Cleanroom Capabilities with $14.2 million Investment